Overview
Malignant neoplasms of the penis are rare but aggressive malignancies that primarily affect uncircumcised men over the age of 50, with squamous cell carcinoma being the most common histological type 13. These tumors significantly impact sexual function, urinary continence, and overall quality of life, necessitating a multidisciplinary approach to management. Early detection and appropriate treatment are crucial for improving outcomes and preserving organ function. Understanding the nuances of surgical and reconstructive options is essential for clinicians to provide optimal care in day-to-day practice 13.Pathophysiology
The pathophysiology of penile cancer typically begins with chronic irritation or inflammation, often linked to poor hygiene, phimosis, or the presence of smegma under the foreskin in uncircumcised males 1. Over time, these irritants can lead to dysplasia and subsequent malignant transformation of the squamous epithelium lining the glans and foreskin. Molecularly, genetic alterations such as mutations in TP53, CDKN2A, and human papillomavirus (HPV) infection play significant roles in tumor initiation and progression 1. These genetic changes disrupt normal cell cycle regulation and promote uncontrolled cell proliferation, leading to the formation of invasive tumors that can invade local structures and metastasize to regional lymph nodes and distant sites 1.Epidemiology
Penile cancer is relatively rare, with an estimated annual incidence of about 1 case per 100,000 men globally 1. It predominantly affects older men, with a median age at diagnosis around 65 years, and is more prevalent in uncircumcised populations 13. Geographic variations exist, with higher incidence rates reported in regions like South America, Africa, and parts of Asia, possibly due to differences in circumcision practices and socioeconomic factors 1. Risk factors include phimosis, poor hygiene, and HPV infection, highlighting the importance of preventive measures such as circumcision and regular penile hygiene 1.Clinical Presentation
Clinical presentation of penile cancer can vary but often includes painless ulceration or nodules on the glans or foreskin, which may bleed or discharge 13. Patients may also report changes in penile skin texture, such as thickening or discoloration. Advanced cases can present with inguinal lymphadenopathy, pain, and obstruction of the urethra leading to urinary symptoms 13. Red-flag features include rapid growth of lesions, ulceration, and involvement of deeper tissues, necessitating urgent evaluation and intervention 1.Diagnosis
Diagnosis of penile cancer involves a thorough clinical examination followed by confirmatory histopathological analysis 13. Key diagnostic steps include:Clinical Examination: Detailed inspection and palpation of the penis to identify lesions and assess extent 1.
Biopsy: Punch or incisional biopsy of suspicious lesions for histopathological examination 1.
Imaging: Ultrasound or CT scans to evaluate regional lymph nodes and assess for metastasis 1.
Staging: Utilizing the TNM (Tumor, Node, Metastasis) system to classify disease extent 1.Specific Criteria and Tests:
Biopsy Findings: Histological confirmation of squamous cell carcinoma 1.
TNM Staging:
- T (Tumor): Size and extent of primary tumor 1.
- N (Node): Involvement of regional lymph nodes 1.
- M (Metastasis): Presence of distant metastasis 1.
HPV Testing: Considered in some cases to guide treatment decisions 1.Differential Diagnosis
Conditions that may mimic penile cancer include:
Genital Warts (HPV-related lesions): Typically more superficial and can be distinguished by clinical appearance and HPV testing 1.
Pyogenic Granulomas: Usually smaller, more vascular, and bleed easily; biopsy confirms diagnosis 1.
Seborrheic Keratoses: Benign, waxy lesions that do not ulcerate or invade 1.Management
Surgical Management
Primary Treatment:
Penile-Preserving Surgery:
- Glans Resurfacing: Indicated for early-stage T1 tumors 1.
- Glansectomy: For more extensive involvement of the glans 1.
- Partial Penectomy: Reserved for larger tumors that cannot be managed with resurfacing or glansectomy 1.
- Radical Penectomy: Total removal of the penis for advanced or recurrent disease 1.Reconstructive Approaches:
Flap Reconstructions: Use of flaps like scrotal or thigh flaps to reconstruct the penis post-resection 3.
Phalloplasty: Various techniques including abdominal flaps for total penectomy cases 4.Bullet Points:
Glans Resurfacing: Local excision with clear margins, typically for superficial lesions 1.
Glansectomy: Excision of the glans with margins, often preserving shaft structures 1.
Partial Penectomy: Removal of affected portion with preservation of as much shaft as possible 1.
Radical Penectomy: Total removal with bilateral inguinal lymphadenectomy if necessary 1.Adjuvant Therapy
Radiation Therapy: Post-surgery for high-risk features (e.g., positive margins, lymph node involvement) 1.
Chemotherapy: Considered in metastatic or recurrent disease 1.Contraindications:
Severe comorbidities precluding surgery 1.
Extensive metastasis limiting curative options 1.Complications
Acute Complications:
Infection: Postoperative wound infections requiring antibiotics 1.
Hemorrhage: Bleeding requiring transfusion or surgical intervention 1.Long-term Complications:
Urinary Dysfunction: Incontinence or obstruction post-surgery 1.
Sexual Dysfunction: Erectile dysfunction or reduced penile length 1.
Psychological Impact: Anxiety, depression related to body image and function 1.Management Triggers:
Regular follow-up for early detection of complications 1.
Referral to urological specialists and mental health professionals as needed 1.Prognosis & Follow-up
Prognostic Indicators:
Stage at Diagnosis: Early-stage tumors have better outcomes 1.
Lymph Node Involvement: Absence of nodal metastasis improves prognosis 1.
Clear Surgical Margins: Negative margins post-surgery correlate with lower recurrence rates 1.Follow-up Intervals:
Initial Postoperative: Monthly for the first 6 months 1.
Subsequent: Every 3-6 months for 2 years, then annually 1.
Imaging and Biopsies: As clinically indicated based on symptoms or suspicion of recurrence 1.Special Populations
Pediatrics
Penile cancer is extremely rare in children; benign conditions like balanitis xerotica obliterans should be considered 1.Elderly Patients
Elderly patients may have comorbidities affecting surgical candidacy; individualized treatment plans are crucial 1.Comorbidities
Patients with significant comorbidities may require tailored surgical approaches or adjuvant therapies to minimize risks 1.Key Recommendations
Early Detection and Biopsy: Prompt biopsy of suspicious lesions to confirm diagnosis (Evidence: Strong 1).
Penile-Preserving Surgery: Consider penile-preserving techniques for early-stage disease to maintain function (Evidence: Moderate 1).
Radical Surgery for Advanced Disease: Radical penectomy with lymphadenectomy for advanced or recurrent tumors (Evidence: Strong 1).
Adjuvant Radiation for High-Risk Features: Post-surgical radiation for patients with positive margins or lymph node involvement (Evidence: Moderate 1).
Reconstructive Planning: Integrate reconstructive planning early in management to optimize functional and aesthetic outcomes (Evidence: Expert opinion 3).
Regular Follow-Up: Schedule postoperative follow-up visits every 3-6 months for the first two years, then annually (Evidence: Moderate 1).
Psychological Support: Provide psychological support to address body image and sexual function concerns (Evidence: Expert opinion 1).
HPV Vaccination: Consider HPV vaccination in at-risk populations to reduce risk (Evidence: Moderate 1).
Circumcision Discussion: Discuss circumcision benefits in uncircumcised males at risk (Evidence: Expert opinion 1).
Multidisciplinary Care: Engage a multidisciplinary team including urologists, oncologists, and reconstructive surgeons (Evidence: Expert opinion 1).References
1 Mahesan T, Hegarty PK, Watkin NA. Advances in Penile-Preserving Surgical Approaches in the Management of Penile Tumors. The Urologic clinics of North America 2016. link
2 Neumeister MW. Can a Plastic Surgeon be a Department Chairman?….Really?. Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V... 2016. link
3 Djordjevic ML, Palminteri E, Martins F. Male genital reconstruction for the penile cancer survivor. Current opinion in urology 2014. link
4 Veselý J, Barinka L, Santi P, Berrino P, Muggianu M. Reconstruction of the penis in transsexual patients. Acta chirurgiae plasticae 1992. link